302
Views
10
CrossRef citations to date
0
Altmetric
Review

Existing Data Sources in Clinical Epidemiology: The Taiwan National Health Insurance Laboratory Databases

, , ORCID Icon, , & ORCID Icon
Pages 175-181 | Published online: 01 Mar 2021

References

  • Chiang TL. Taiwan’s 1995 health care reform. Health Policy. 1997;39(3):225–239. doi:10.1016/S0168-8510(96)00877-910165463
  • Cheng TM. Taiwan’s new national health insurance program: genesis and experience so far. Health Aff. 2003;22(3):61–76. doi:10.1377/hlthaff.22.3.61
  • Cheng TM. Reflections on the 20th anniversary of Taiwan’s single-payer National Health Insurance System. Health Aff. 2015;34:502–510. doi:10.1377/hlthaff.2014.1332
  • Hsing AW, Ioannidis JPA. Nationwide population science: lessons from the Taiwan National Health Insurance Research Database. JAMA Intern Med. 2015;175(9):1527–1529. doi:10.1001/jamainternmed.2015.354026192815
  • Lin LY, Warren-Gash C, Smeeth L, Chen PC. Data resource profile: the National Health Insurance Research Database (NHIRD). Epidemiol Health. 2018;40:e2018062. doi:10.4178/epih.e201806230727703
  • Hsieh CY, Su CC, Shao SC, et al. Taiwan’s national health insurance research database: past and future. Clin Epidemiol. 2019;11:349–358. doi:10.2147/CLEP.S19629331118821
  • Taiwan NHI papers search. Accessed at 110, 2021. https://visualizinghealthdata.idv.tw/?route=article/thesis.
  • Lee TT, Cheng SH, Chen CC, Lai MS. A pay-for-performance program for diabetes care in Taiwan: a preliminary assessment. Am J Manag Care. 2010;16(1):65.20148607
  • Chen TT, Chung KP, Lin IC, Lai MS. The unintended consequence of diabetes mellitus pay‐for‐performance (P4P) program in Taiwan: are patients with more comorbidities or more severe conditions likely to be excluded from the P4P program? Health Serv Res. 2011;46(1p1):47–60. doi:10.1111/j.1475-6773.2010.01182.x20880044
  • Hsieh HM, Gu SM, Shin SJ, Kao HY, Lin YC, Chiu HC. Cost-effectiveness of a diabetes pay-for-performance program in diabetes patients with multiple chronic conditions. PLoS One. 2015;10:e0133163. doi:10.1371/journal.pone.013316326173086
  • Huang SK, Wang PJ, Tseng WF, et al. NHI-PharmaCloud in Taiwan—a preliminary evaluation using the RE-AIM framework and lessons learned. Int J Med Inform. 2015;84(10):817–825. doi:10.1016/j.ijmedinf.2015.06.00126113462
  • Tseng YT, Chang EH, Kuo LN, et al. Preliminary physician and pharmacist survey of the National Health Insurance PharmaCloud system in Taiwan. Comput Methods Programs Biomed. 2017;149:69–77. doi:10.1016/j.cmpb.2017.07.00428802331
  • Liu MC, Lee CC. (2018). An investigation of pharmacists’ acceptance of NHI-PharmaCloud in Taiwan. J Med Syst. 2018;42(11):213. doi:10.1007/s10916-018-1017-330264375
  • Liao CY, Wu MF, Poon SK, et al. Improving medication safety by cloud technology: progression and value-added applications in Taiwan. Int J Med Inform. 2019;126:65–71. doi:10.1016/j.ijmedinf.2019.03.01231029265
  • Chiang H, Chang C. Introduction to and application analysis of Taiwan’s NHI-MediCloud System. J Serv Sci Res. 2019;11:93–115. doi:10.1007/s12927-019-0005-6
  • Rau HH, Wu YS, Chu CM, et al. Importance-performance analysis of personal health records in Taiwan: a web-based survey. J Med Internet Res. 2017;19(4):e131. doi:10.2196/jmir.706528450273
  • Hsu MH. Chapter 11: health Information Technology. In: Chiang TL, SH C, editors. Health Care Policy in East Asia: A World Scientific Reference Volume 4: Health Care System Reform and Policy Research in Taiwan. Singapore: World Scientific Publishing Co. 2020:197–205.
  • Taiwan National Health Insurance Administration. Guidelines for uploading the results of laboratory tests and reports of examinations. Accessed at https://www.nhi.gov.tw/Content_List.aspx?n=264416706E2EF4DA&topn=D39E2B72B0BDFA15. 8 30, 2019.
  • Pretorius C. Utilisation of pathology procedures in the South African private pathology sector between 2003 and 2005. S Afr Med J. 2007;97:51–57.17378283
  • Makuwaza L, Musarurwa C, Goma Z. Evaluation of cost per test of clinical biochemistry tests at Parirenyatwa Central Hospital Laboratory, Harare, Zimbabwe. Cen Afr J Med. 2009;55:59–63.
  • Grann AF, Erichsen R, Nielsen AG, Froslev T, Thomsen RW. Existing data sources for clinical epidemiology: the clinical laboratory information system (LABKA) research database at Aarhus University, Denmark. Clin Epidemiol. 2011;3:133–138. doi:10.2147/CLEP.S1790121487452
  • Horton S, Sullivan R, Flaningan J, et al. The top 25 laboratory tests by volume and revenue in five different countries. Lancet. 2018;391:1953–1964. doi:10.1016/S0140-6736(18)30460-429550030
  • Horton S, Fleming KA, Kuti MA, Looi LM, Pai SA, Lawler M. Delivering modern, high quality, affordable pathology and laboratory medicine to low-income and middle-income countries: a call to action. Am J Clin Pathol. 2019;151:446–451. doi:10.1093/ajcp/aqy16530535132
  • Arendt JFH, Hansen AT, Ladefoged SA, Sørensen HT, Pedersen L, Adelborg K. Existing data sources in clinical epidemiology: laboratory information system databases in Denmark. Clin Epidemiol. 2020;12:469–475. doi:10.2147/CLEP.S24506032547238
  • Sheu MJ, Ling FW, Li ST, Li CY, Lu TH. Validity of ICD-10-CM codes used to identify patients with chronic hepatitis B and C virus infection in administrative claims data from the Taiwan National Health Insurance outpatient claims dataset. Clin Epidemiol. 2020;12:185–192. doi:10.2147/CLEP.S23682332110110